• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发合成工具以破译肿瘤免疫互作组。

Developing synthetic tools to decipher the tumor-immune interactome.

机构信息

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520.

Department of Ophthalmology, Yale University School of Medicine, New Haven, CT 06520.

出版信息

Proc Natl Acad Sci U S A. 2023 Oct 31;120(44):e2306632120. doi: 10.1073/pnas.2306632120. Epub 2023 Oct 23.

DOI:10.1073/pnas.2306632120
PMID:37871202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10622925/
Abstract

The ability of immune cells to directly interact with transformed cells is an essential component of immune surveillance and critical for optimal tissue function. The tumor-immune interactome (the collective cellular interactions between oncogenic cells and immune cells) is distinct and varied based on the tissue location and immunogenicity of tumor subtypes. However, comprehensive landscape and the consequences of tumor-interacting immune cells in the tumor microenvironment are not well understood. Current tools are limited in their ability to identify and record interactors in vivo or be utilized for downstream analysis. Here, we describe the development and validation of a technology leveraging synthetic Notch receptors reporting physical tumor cell-immune cell contact in vivo in order to decipher the tumor-immune interactome. We call this approach, Tumor-Immune Interactome Non-biased Discovery Retroviral Reporter or TIINDRR. Using TIINDRR, we identify the tumor-immune interactomes that define immunological refractory and sensitive tumors and how different immunotherapies alter these interactions. Thus, TIINDRR provides a flexible and versatile tool for studying in-vivo tumor-immune cell interactions, aiding in the identification of biologically relevant information needed for the rational design of immune-based therapies.

摘要

免疫细胞直接与转化细胞相互作用的能力是免疫监视的重要组成部分,对于组织的最佳功能至关重要。肿瘤免疫相互作用组(致癌细胞和免疫细胞之间的集体细胞相互作用)因组织位置和肿瘤亚型的免疫原性而异。然而,肿瘤微环境中肿瘤相互作用的免疫细胞的全面情况及其后果尚不清楚。目前的工具在识别和记录体内相互作用因子的能力或用于下游分析方面存在局限性。在这里,我们描述了一种利用合成 Notch 受体在体内报告实体瘤细胞-免疫细胞物理接触的技术的开发和验证,以破译肿瘤免疫相互作用组。我们将这种方法称为肿瘤-免疫相互作用组无偏发现逆转录病毒报告基因或 TIINDRR。使用 TIINDRR,我们确定了定义免疫难治性和敏感性肿瘤的肿瘤免疫相互作用组,以及不同免疫疗法如何改变这些相互作用。因此,TIINDRR 为研究体内肿瘤-免疫细胞相互作用提供了一种灵活多样的工具,有助于识别基于免疫的治疗的合理设计所需的生物学相关信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/ffd5fd2b68ce/pnas.2306632120fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/34340823eed2/pnas.2306632120fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/f7537ee6ed12/pnas.2306632120fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/c061dee7254b/pnas.2306632120fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/f5dfc2c78748/pnas.2306632120fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/ffd5fd2b68ce/pnas.2306632120fig05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/34340823eed2/pnas.2306632120fig01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/f7537ee6ed12/pnas.2306632120fig02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/c061dee7254b/pnas.2306632120fig03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/f5dfc2c78748/pnas.2306632120fig04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1873/10622925/ffd5fd2b68ce/pnas.2306632120fig05.jpg

相似文献

1
Developing synthetic tools to decipher the tumor-immune interactome.开发合成工具以破译肿瘤免疫互作组。
Proc Natl Acad Sci U S A. 2023 Oct 31;120(44):e2306632120. doi: 10.1073/pnas.2306632120. Epub 2023 Oct 23.
2
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.黑色素瘤研究的未来展望:“黑色素瘤桥梁”会议报告。那不勒斯,2015年12月1日至4日
J Transl Med. 2016 Nov 15;14(1):313. doi: 10.1186/s12967-016-1070-y.
3
Immunological-based approaches for cancer therapy.基于免疫学的癌症治疗方法。
Clinics (Sao Paulo). 2018 Aug 20;73(suppl 1):e429s. doi: 10.6061/clinics/2018/e429s.
4
Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.纳米免疫工程在癌症免疫治疗中的应用:超 pH 敏感纳米颗粒的启示。
Acc Chem Res. 2020 Nov 17;53(11):2546-2557. doi: 10.1021/acs.accounts.0c00475. Epub 2020 Oct 16.
5
Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.髓系细胞中的Notch信号传导作为肿瘤免疫反应的调节因子
Front Immunol. 2018 Jun 4;9:1288. doi: 10.3389/fimmu.2018.01288. eCollection 2018.
6
Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.细胞因子在肿瘤微环境中协调自然杀伤细胞与髓系细胞的相互作用:对基于自然杀伤细胞的癌症免疫治疗的意义。
Front Immunol. 2021 Jan 29;11:621225. doi: 10.3389/fimmu.2020.621225. eCollection 2020.
7
Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.促甲状腺滤泡癌细胞间通讯中断可作为免疫治疗机会
Adv Exp Med Biol. 2021;1350:33-66. doi: 10.1007/978-3-030-83282-7_2.
8
Overview of Basic Immunology and Clinical Application.基础免疫学概述及其临床应用。
Adv Exp Med Biol. 2020;1244:1-36. doi: 10.1007/978-3-030-41008-7_1.
9
Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1.破骨细胞在多发性骨髓瘤中的免疫抑制作用:程序性细胞死亡配体 1 的作用。
Front Immunol. 2018 Aug 10;9:1822. doi: 10.3389/fimmu.2018.01822. eCollection 2018.
10
From cancer immunosurveillance to cancer immunotherapy.从癌症免疫监视到癌症免疫治疗。
Immunol Rev. 2007 Dec;220:82-101. doi: 10.1111/j.1600-065X.2007.00566.x.

引用本文的文献

1
Mendelian Randomization Analysis Supports a Causal Relationship Between Circulating Inflammatory Proteins and Basal Cell Carcinoma.孟德尔随机化分析支持循环炎症蛋白与基底细胞癌之间的因果关系。
Clin Cosmet Investig Dermatol. 2025 Mar 31;18:767-779. doi: 10.2147/CCID.S521068. eCollection 2025.
2
Universal recording of immune cell interactions in vivo.在体实时记录免疫细胞相互作用。
Nature. 2024 Mar;627(8003):399-406. doi: 10.1038/s41586-024-07134-4. Epub 2024 Mar 6.

本文引用的文献

1
A neutrophil response linked to tumor control in immunotherapy.免疫治疗中与肿瘤控制相关的中性粒细胞反应。
Cell. 2023 Mar 30;186(7):1448-1464.e20. doi: 10.1016/j.cell.2023.02.032.
2
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants.T 细胞免疫疗法利用中性粒细胞消除肿瘤抗原逃逸变体。
Cell. 2023 Mar 30;186(7):1432-1447.e17. doi: 10.1016/j.cell.2023.03.007.
3
Type 2 Dendritic Cells Orchestrate a Local Immune Circuit to Confer Antimetastatic Immunity.2 型树突状细胞协调局部免疫回路赋予抗肿瘤免疫。
J Immunol. 2023 Apr 15;210(8):1146-1155. doi: 10.4049/jimmunol.2200697.
4
A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer.人类乳腺癌中 T 细胞耗竭相关免疫环境的全面单细胞图谱
Nat Commun. 2023 Jan 6;14(1):98. doi: 10.1038/s41467-022-35238-w.
5
The ectonucleotidase CD39 identifies tumor-reactive CD8 T cells predictive of immune checkpoint blockade efficacy in human lung cancer.细胞外核苷酸酶 CD39 鉴定出预测人类肺癌免疫检查点阻断疗效的肿瘤反应性 CD8 T 细胞。
Immunity. 2023 Jan 10;56(1):93-106.e6. doi: 10.1016/j.immuni.2022.12.001. Epub 2022 Dec 26.
6
Monitoring of cell-cell communication and contact history in mammals.监测哺乳动物细胞间通讯和接触史。
Science. 2022 Dec 2;378(6623):eabo5503. doi: 10.1126/science.abo5503.
7
Metabolic reprogramming of terminally exhausted CD8 T cells by IL-10 enhances anti-tumor immunity.IL-10 通过代谢重编程终末耗竭 CD8 T 细胞增强抗肿瘤免疫。
Nat Immunol. 2021 Jun;22(6):746-756. doi: 10.1038/s41590-021-00940-2. Epub 2021 May 24.
8
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment.单细胞分析鉴定出循环抗肿瘤 CD8 T 细胞及其富集标志物。
J Exp Med. 2021 Apr 5;218(4). doi: 10.1084/jem.20200920.
9
T cell circuits that sense antigen density with an ultrasensitive threshold.T 细胞具有超敏阈感知抗原密度的回路。
Science. 2021 Mar 12;371(6534):1166-1171. doi: 10.1126/science.abc1855. Epub 2021 Feb 25.
10
Precise T cell recognition programs designed by transcriptionally linking multiple receptors.通过转录连接多个受体设计精确的 T 细胞识别程序。
Science. 2020 Nov 27;370(6520):1099-1104. doi: 10.1126/science.abc6270.